CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (5y) (2022 - 2026)
CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -433,627.00 |
| Dec 31, 2025 | -515,873.00 |
| Sep 30, 2025 | -1.77 Bn |
| Jun 30, 2025 | 200,786.00 |
| Mar 30, 2025 | 20,010.00 |
| Dec 31, 2024 | -183,183.00 |
| Sep 30, 2024 | -11.33 Mn |
| Jun 30, 2024 | 147,888.00 |
| Mar 31, 2024 | 416,028.00 |
| Dec 31, 2023 | -167,762.00 |
| Sep 30, 2023 | -68,305.00 |
| Jun 30, 2023 | -70,744.00 |
| Mar 31, 2023 | -11,441.00 |
| Dec 31, 2022 | -871,116.00 |